vs
AVALON HOLDINGS CORP（AWX）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
AVALON HOLDINGS CORP的季度营收约是STANDARD BIOTOOLS INC.的1.1倍（$21.5M vs $19.6M），AVALON HOLDINGS CORP净利率更高（-1.7% vs -177.4%，领先175.8%），AVALON HOLDINGS CORP同比增速更快（21.7% vs -11.5%），AVALON HOLDINGS CORP自由现金流更多（$-166.0K vs $-23.1M），过去两年AVALON HOLDINGS CORP的营收复合增速更高（6.7% vs -12.2%）
阿瓦隆山游戏公司是一家专业出版兵棋推演与策略桌游的游戏企业，业务也涵盖微缩兵棋规则、角色扮演游戏及体育模拟类游戏的出版。该公司隶属于孩之宝，在孩之宝旗下的游戏事业部开展运营。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
AWX vs LAB — 直观对比
营收规模更大
AWX
是对方的1.1倍
$19.6M
营收增速更快
AWX
高出33.2%
-11.5%
净利率更高
AWX
高出175.8%
-177.4%
自由现金流更多
AWX
多$22.9M
$-23.1M
两年增速更快
AWX
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.5M | $19.6M |
| 净利润 | $-356.0K | $-34.7M |
| 毛利率 | 17.1% | 48.5% |
| 营业利润率 | 0.4% | -168.5% |
| 净利率 | -1.7% | -177.4% |
| 营收同比 | 21.7% | -11.5% |
| 净利润同比 | 28.4% | -28.8% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AWXLAB
| Q4 25 | $21.5M | — | ||
| Q3 25 | $25.7M | $19.6M | ||
| Q2 25 | $20.3M | $21.8M | ||
| Q1 25 | $16.1M | $40.8M | ||
| Q4 24 | $17.6M | — | ||
| Q3 24 | $24.2M | $22.1M | ||
| Q2 24 | $23.1M | $22.5M | ||
| Q1 24 | $18.9M | $45.5M |
净利润AWXLAB
| Q4 25 | $-356.0K | — | ||
| Q3 25 | $1.9M | $-34.7M | ||
| Q2 25 | $274.0K | $-33.5M | ||
| Q1 25 | $-1.5M | $-26.0M | ||
| Q4 24 | $-497.0K | — | ||
| Q3 24 | $1.8M | $-26.9M | ||
| Q2 24 | $954.0K | $-45.7M | ||
| Q1 24 | $-979.0K | $-32.2M |
毛利率AWXLAB
| Q4 25 | 17.1% | — | ||
| Q3 25 | 23.7% | 48.5% | ||
| Q2 25 | 20.6% | 48.8% | ||
| Q1 25 | 14.8% | 48.4% | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 24.6% | 54.9% | ||
| Q2 24 | 22.1% | 46.1% | ||
| Q1 24 | 16.2% | 53.1% |
营业利润率AWXLAB
| Q4 25 | 0.4% | — | ||
| Q3 25 | 9.1% | -168.5% | ||
| Q2 25 | 3.7% | -118.1% | ||
| Q1 25 | -7.2% | -80.8% | ||
| Q4 24 | -0.8% | — | ||
| Q3 24 | 9.4% | -120.9% | ||
| Q2 24 | 6.3% | -134.5% | ||
| Q1 24 | -2.7% | -132.2% |
净利率AWXLAB
| Q4 25 | -1.7% | — | ||
| Q3 25 | 7.4% | -177.4% | ||
| Q2 25 | 1.4% | -153.7% | ||
| Q1 25 | -9.3% | -63.8% | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | 7.6% | -122.0% | ||
| Q2 24 | 4.1% | -203.3% | ||
| Q1 24 | -5.2% | -70.6% |
每股收益（稀释后）AWXLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.1M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $38.4M | $399.7M |
| 总资产 | $87.4M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AWXLAB
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.6M | $129.4M | ||
| Q2 25 | $3.7M | $158.6M | ||
| Q1 25 | $1.3M | $150.9M | ||
| Q4 24 | $2.8M | — | ||
| Q3 24 | $3.9M | $210.6M | ||
| Q2 24 | $3.8M | $269.8M | ||
| Q1 24 | $1.2M | $287.1M |
总债务AWXLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益AWXLAB
| Q4 25 | $38.4M | — | ||
| Q3 25 | $38.7M | $399.7M | ||
| Q2 25 | $36.8M | $424.5M | ||
| Q1 25 | $36.5M | $454.6M | ||
| Q4 24 | $38.0M | — | ||
| Q3 24 | $38.5M | $489.3M | ||
| Q2 24 | $36.7M | $510.3M | ||
| Q1 24 | $35.7M | $577.3M |
总资产AWXLAB
| Q4 25 | $87.4M | — | ||
| Q3 25 | $90.7M | $539.6M | ||
| Q2 25 | $88.1M | $557.0M | ||
| Q1 25 | $87.6M | $579.6M | ||
| Q4 24 | $86.2M | — | ||
| Q3 24 | $89.1M | $681.5M | ||
| Q2 24 | $91.7M | $708.7M | ||
| Q1 24 | $90.6M | $777.7M |
负债/权益比AWXLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $278.0K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-166.0K | $-23.1M |
| 自由现金流率自由现金流/营收 | -0.8% | -118.1% |
| 资本支出强度资本支出/营收 | 2.1% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $2.1M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流AWXLAB
| Q4 25 | $278.0K | — | ||
| Q3 25 | $1.5M | $-22.2M | ||
| Q2 25 | $3.0M | $-20.7M | ||
| Q1 25 | $-982.0K | $-30.3M | ||
| Q4 24 | $-579.0K | — | ||
| Q3 24 | $342.0K | $-27.9M | ||
| Q2 24 | $3.2M | $-39.0M | ||
| Q1 24 | $411.0K | $-62.5M |
自由现金流AWXLAB
| Q4 25 | $-166.0K | — | ||
| Q3 25 | $852.0K | $-23.1M | ||
| Q2 25 | $2.7M | $-22.6M | ||
| Q1 25 | $-1.4M | $-35.3M | ||
| Q4 24 | $-1.1M | — | ||
| Q3 24 | $-660.0K | $-30.1M | ||
| Q2 24 | $2.9M | $-41.0M | ||
| Q1 24 | $56.0K | $-63.3M |
自由现金流率AWXLAB
| Q4 25 | -0.8% | — | ||
| Q3 25 | 3.3% | -118.1% | ||
| Q2 25 | 13.5% | -103.6% | ||
| Q1 25 | -8.5% | -86.6% | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -2.7% | -136.4% | ||
| Q2 24 | 12.4% | -182.2% | ||
| Q1 24 | 0.3% | -138.9% |
资本支出强度AWXLAB
| Q4 25 | 2.1% | — | ||
| Q3 25 | 2.3% | 4.5% | ||
| Q2 25 | 1.4% | 8.7% | ||
| Q1 25 | 2.4% | 12.4% | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 4.1% | 10.2% | ||
| Q2 24 | 1.5% | 8.6% | ||
| Q1 24 | 1.9% | 1.7% |
现金转化率AWXLAB
| Q4 25 | — | — | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 11.07× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 3.35× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AWX
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
